| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-05 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.12 | 0.004 |